News Detail

Date/Time
28 Feb 2022 17:52:00
Headline
Report on the results of the sale of warrants offered to existing common shareholders (F53-5) (Edti)
Symbol
HEMP
Source
HEMP
Full Detailed News
Download Full Detailed News
                The results of the sale of Warrants/TSR (F53-5)
Report date of securities allocation     : 28-Feb-2022

Type of offered securities

Warrant
Offered to

Existing common shareholders
Number of offered warrants (units)       : 177,849,750
Warrant trading symbol                   : HEMP-W2
Name of warrant                          : Warrants to Purchase Ordinary Shares 
of Health Empire Corporation Public Company Limited Series 2
Offering price (baht per unit)           : 0.00
Allocation date                          : 28-Feb-2022
Number of allotted/subscribed warrants   : 177,816,294
(units) (Update)
Number of remaining warrants (unit)      : 33,456
(Update)
The company will deal with the remaining : Should there be any fraction of the 
HEMP-W2 Warrants remaining from the calculation of allocation ratio, such
fraction shall be discarded. All of the HEMP-W2 Warrants remaining from the
allocation shall be cancelled by the Company, and as such, the balance of the
HEMP-W2 Warrants will be equal to the number allocated to the shareholders
without fraction.
 warrants as follows
________________________________________________________________________________
___________________


Authorized to sign on behalf of the      : Mr. Samart Chuasiriphattana
company
Position                                 : Director

Mr. Sittichai Gasornsombat
Director

______________________________________________________________________
This announcement was prepared and disseminated by listed company or issuer 
through the electronic system which is provided for the purpose of dissemination
of the information and related documents of listed company or issuer to the
Stock Exchange of Thailand only.  The Stock Exchange of Thailand has   no
responsibility for the correctness and completeness of any statements, figures,
reports or opinions contained in this announcement, and has no liability for any
losses and damages in any cases.  In case you have any inquiries or
clarification regarding this announcement, please directly contact listed
company or issuer who made this announcement.